International Prospective Registry on Local Treatment Approaches in MLS

Status Recruiting

Clinical Trial Summary

To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)

Clinical Trial Description

In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04699292
Study type	Observational [Patient Registry]
Source	The Netherlands Cancer Institute
Contact	Rick Haas, MD/PhD
Phone	+31 20 512 9111
Email	r.haas@nki.nl
Status	Recruiting
Phase
Start date	January 18, 2021
Completion date	January 2031

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01957709` - Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma	Early Phase 1
Active, not recruiting	`NCT03600649` - Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas	Phase 1
Completed	`NCT02821507` - Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma	Phase 2
Withdrawn	`NCT03397186` - Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma	Phase 2
Active, not recruiting	`NCT03989596` - Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas	Phase 2
Enrolling by invitation	`NCT05266196` - A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)	Phase 1/Phase 2
Recruiting	`NCT05492682` - START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer	Phase 1
Active, not recruiting	`NCT03651375` - Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall	Phase 2
Active, not recruiting	`NCT00633165` - Brostallicin Clinical Trial for Myxoid Liposarcoma	Phase 2
Recruiting	`NCT04044768` - Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma	Phase 2
Active, not recruiting	`NCT03816475` - Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)	Phase 2